Related Experiment Video

Updated: Aug 29, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Cholesterol changes in coronary patients after a short behavior modification program

Ellen H Sebregts1, Paul R Falger, Frits W Bär

  • 1Department of Medical, Clinical and Experimental Psychology, Maastricht University, Maastricht, The Netherlands. ehwj.sebregts@adhesie.nl

International Journal of Behavioral Medicine
|January 22, 2004
PubMed

Insights

A behavior modification program effectively reduced total cholesterol and LDL cholesterol in coronary artery disease patients, especially those with high baseline levels. The intervention showed sustained benefits even after adjusting for statin use.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Clinical Trials

Background:

  • Coronary artery disease (CAD) management requires effective strategies to control lipid levels.
  • Behavior modification programs show potential in improving cardiovascular health outcomes.
  • Understanding the impact of lifestyle interventions on cholesterol is crucial for patient care.

Purpose of the Study:

  • To evaluate the efficacy of an 8-week behavior modification program on serum cholesterol levels in patients with coronary artery disease (CAD).
  • To assess the long-term effects of the intervention on total cholesterol, LDL, and HDL cholesterol.
  • To determine if the intervention's effectiveness is influenced by baseline lipid levels and statin use.

Main Methods:

  • A randomized controlled clinical trial involving patients with acute myocardial infarction (AMI) or coronary artery bypass grafting (CABG).
  • Patients were assigned to either an intervention group (behavior modification program) or a usual care control group.
  • Serum cholesterol levels were monitored over a 9-month follow-up period, with adjustments for statin dose changes.

Main Results:

  • The behavior modification program significantly reduced total cholesterol and LDL cholesterol, particularly in patients with high baseline lipid levels.
  • Even after accounting for statin dose adjustments, favorable effects on total and LDL cholesterol persisted in high-baseline lipid patients (20% and 29% reduction, respectively).
  • Unexpectedly, HDL cholesterol showed a lower increase in the intervention group compared to the control group.

Conclusions:

  • Behavior modification is an effective strategy for lowering total and LDL cholesterol in CAD patients, offering sustained benefits.
  • The intervention's impact is more pronounced in individuals with elevated baseline cholesterol levels.
  • Further research is needed to understand the mechanisms behind the observed HDL cholesterol changes.

More Related Videos

Cholesterol Efflux Assay07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...